Terai, Y.L.; Huang, C.; Wang, B.; Kang, X.; Han, J.; Douglass, J.; Hsiue, E.H.-C.; Zhang, M.; Purohit, R.; deSilva, T.;
et al. Valid-NEO: A Multi-Omics Platform for Neoantigen Detection and Quantification from Limited Clinical Samples. Cancers 2022, 14, 1243.
https://doi.org/10.3390/cancers14051243
AMA Style
Terai YL, Huang C, Wang B, Kang X, Han J, Douglass J, Hsiue EH-C, Zhang M, Purohit R, deSilva T,
et al. Valid-NEO: A Multi-Omics Platform for Neoantigen Detection and Quantification from Limited Clinical Samples. Cancers. 2022; 14(5):1243.
https://doi.org/10.3390/cancers14051243
Chicago/Turabian Style
Terai, Yuri Laguna, Chun Huang, Baoli Wang, Xiaonan Kang, Jing Han, Jacqueline Douglass, Emily Han-Chung Hsiue, Ming Zhang, Raj Purohit, Taylor deSilva,
and et al. 2022. "Valid-NEO: A Multi-Omics Platform for Neoantigen Detection and Quantification from Limited Clinical Samples" Cancers 14, no. 5: 1243.
https://doi.org/10.3390/cancers14051243
APA Style
Terai, Y. L., Huang, C., Wang, B., Kang, X., Han, J., Douglass, J., Hsiue, E. H.-C., Zhang, M., Purohit, R., deSilva, T., & Wang, Q.
(2022). Valid-NEO: A Multi-Omics Platform for Neoantigen Detection and Quantification from Limited Clinical Samples. Cancers, 14(5), 1243.
https://doi.org/10.3390/cancers14051243